within Pharmacolibrary.Drugs.ATC.L;

model L03AA12
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.0008333333333333334,
    adminDuration  = 600,
    adminMass      = 0.02,
    adminCount     = 1,
    Vd             = 0.0001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Ancestim is a recombinant human stem cell factor (rhSCF) developed to enhance hematopoietic stem cell mobilization in combination with filgrastim for hematopoietic stem cell transplantation. It is not currently approved for clinical use.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic studies or peer-reviewed sources with quantitative pharmacokinetic parameters for ancestim were found. Estimates below are based on its biological class and known clinical use in combination with filgrastim in healthy volunteers.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end L03AA12;
